Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Trichotillomania involves hair pulling and can be treated with therapy and medication.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Different parts of the body have unique immune characteristics in their skin.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Adding a second method to PROTACs could improve cancer treatment.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Tiger cubs fed artificial milk lacking certain amino acids developed eye problems and hair loss.

SIM01 significantly reduced post-COVID symptoms and is safe.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Using powdered umbilical remnant allograft can effectively treat chronic scalp wounds resistant to traditional treatments.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.